慢性淋巴细胞白血病B淋巴细胞TRIP13 mRNA表达及TRIP13介导JVM-2细胞增殖与凋亡的分子机制研究
该研究检测30例慢性淋巴细胞白血病(CLL)患者与12名造血干细胞供者外周血CD19(+) B淋巴细胞TRIP13 mRNA表达,并用慢病毒介导shRNA干扰JVM-2细胞TRIP13,观察细胞增殖与凋亡及相关蛋白变化。CLL患者TRIP13 mRNA表达高于正常对照组;下调TRIP13可抑制JVM-2细胞增殖并诱导凋亡,伴随Myc与Bcl-2蛋白下调、Bax、caspase 3与Bad蛋白上调。
要点
- CLL患者CD19(+) B淋巴细胞TRIP13 mRNA表达高于正常供者(P<0.001)。
- 下调JVM-2细胞TRIP13可抑制增殖并诱导凋亡。
- 干扰TRIP13后JVM-2细胞Myc、Bcl-2蛋白下调,Bax、caspase 3、Bad蛋白上调(P<0.001)。
核心结论
- CLL患者外周血CD19(+) B淋巴细胞TRIP13 mRNA表达上调。
- TRIP13基因通过影响细胞增殖和凋亡相关蛋白表达而调控JVM-2细胞的增殖与凋亡。
研究设计与样本
- 实时荧光定量PCR检测30例CLL患者与12名造血干细胞供者(正常对照组)外周血CD19(+) B淋巴细胞TRIP13 mRNA表达水平。
- 使用慢病毒介导shRNA干扰CLL细胞JVM-2的TRIP13 mRNA和蛋白,随机序列shRNA处理JVM-2细胞作为对照组。
- MTT法和流式细胞术检测TRIP13干扰组与对照组JVM-2细胞的增殖和凋亡。
- Western blot法检测TRIP13干扰对JVM-2细胞凋亡相关蛋白表达的影响。
主要发现
- 30例CLL患者外周血B淋巴细胞TRIP13 mRNA表达水平(2(-△Ct)=0.014 89)高于正常对照组12名供者(2(-△Ct)=0.000 19)(P<0.001)。
- 在JVM-2细胞中筛选出有效干扰shRNA靶点,下调TRIP13表达能够有效抑制JVM-2细胞增殖并促进细胞凋亡。
- 干扰TRIP13后JVM-2细胞Myc和Bcl-2蛋白表达下调(P<0.001),Bax、caspase 3、Bad蛋白表达上调(P<0.001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the clinical significance of expression level of thyroid hormone receptor interactors 13 (TRIP13) gene to probe its function and downstream molecular mechanism in chronic lymphocytic leukemia (CLL) . Methods: Real-time quantitative PCR method was used to detect the expression levels of TRIP13 mRNA of CD19(+) B lymphocytes in 30 cases of patients with CLL and 12 cases of peripheral blood hematopoietic stem cell donors (normal control group) . Lentivirus mediated shRNA was used to interference the mRNA and TRIP13 protein in CLL cells JVM-2. Scramble sequence was used as control. Methyl thiazolyl tetrazolium colorimetric assay (MTT) and flow cytometry was used to detect the cell proliferation and apoptosis in TRIP13 knocked-down and negative control JVM-2 cells. Results: TRIP13 mRNA level was significantly higher in 30 cases of CLL patients (2(-△Ct)= 0.014 89) compared with 12 healthy donors (2(-△Ct)= 0.000 19) (P<0.001) . Validated TRIP13 shRNA target was achieved in JVM2 cell. Compared with the control group, down-regulation of TRIP13 expression could significantly inhibit the proliferation of JVM-2 cells and induce apoptosis. The expressions of Myc and Bcl-2 protein in JVM-2 cells decreased significantly after interference with TRIP13 (P<0.001) , and the expressions of Bax, caspase 3 and Bad protein increased significantly (P<0.001) . Conclusion: TRIP13 mRNA significantly over-expressed in CLL patients CD19(+) B lymphocytes. TRIP13 could influence JVM2 cell proliferation and apoptosis through proliferation- and apoptosis-related proteins. 目的: 探讨甲状腺激素受体相互作用分子13(TRIP13)基因表达和慢性淋巴细胞白血病(CLL)的相关性,验证TRIP13基因在CLL发生发展中发挥的生物学功能,探讨TRIP13基因调控CLL发生发展的下游分子机制。 方法: ①应用实时荧光定量PCR检测30例CLL患者和12名造血干细胞供者(正常对照组)外周血CD19(+) B淋巴细胞TRIP13 mRNA的表达水平。②使用慢病毒介导的shRNA干扰JVM-2细胞TRIP13 mRNA和蛋白表达水平,同时使用随机序列shRNA处理JVM-2细胞作为对照组,分别应用MTT法和流式细胞术检测TRIP13干扰组、对照组JVM-2细胞的增殖和凋亡情况。③Western blot法检测TRIP13干扰对JVM-2细胞凋亡相关蛋白表达的影响。 结果: ①30例CLL患者外周血B淋巴细胞TRIP13 mRNA表达水平(2(-△Ct)= 0.014 89)高于正常对照组(2(-△Ct)= 0.000 19)(P<0.001)。②在JVM2细胞中筛选出有效干扰shRNA靶点,下调TRIP13的表达能够有效抑制JVM-2细胞增殖并促进细胞凋亡。③干扰TRIP13后JVM-2细胞Myc和Bcl-2蛋白表达下调(P<0.001),Bax、caspase3、Bad蛋白表达上调(P<0.001)。 结论: CLL患者外周血CD19(+) B淋巴细胞TRIP13 mRNA表达上调;TRIP13基因通过影响细胞增殖和凋亡相关蛋白表达而调控JVM2细胞的增殖与凋亡。.
引用
- Zhou KS, Zhang Q, Zhang WT, et al. [Study on the expression of TRIP13 mRNA in chronic lymphocytic leukemia B lymphocyte and the molecular mechanism of TRIP13 mediated JVM-2 cell proliferation and apoptosis]. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28810332. doi:10.3760/cma.j.issn.0253-2727.2017.07.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。